Home > Financial Ratios > BAL PHARMA

BAL PHARMA
Core EBITDA Growth

    Back to All Ratios
BAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -5.3928.99-10.0912.99274.74

What is the latest Core EBITDA Growth ratio of BAL PHARMA ?

The latest Core EBITDA Growth ratio of BAL PHARMA is -5.39 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-5.39
Mar202428.99
Mar2023-10.09
Mar202212.99
Mar2021274.74

How is Core EBITDA Growth of BAL PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 -5.39
Negative
Mar2024 28.99
Positive
Mar2023 -10.09
Negative
Mar2022 12.99
-95.27
Mar2021 274.74 -

Other Financial Ratios of BAL PHARMA


Compare Core EBITDA Growth ratio of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹126.7 Cr 3.6% -7.4% -23.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹464,331.0 Cr 1.2% 8.3% 15.5% Stock Analytics
DIVIS LABORATORIES ₹181,466.0 Cr -0.2% 3% -0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹165,952.0 Cr 1.7% 9.9% 46.8% Stock Analytics
CIPLA ₹116,229.0 Cr -2.2% 4.5% -4.4% Stock Analytics
DR REDDYS LABORATORIES ₹103,959.0 Cr -9% -2.1% -1.8% Stock Analytics


BAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

3.6%

-7.4%

-23.4%

SENSEX

-0.3%

4.9%

-7%


You may also like the below Video Courses